KAREN DEAL: Open Payments
NPI 1427512334 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 10 payments from 6 companies in 2025. Trend: 2023 $638 · 2024 $243 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $209 |
| KYOWA KIRIN, INC. | 1 | $129 |
| Amgen Inc. | 2 | $119 |
| Novo Nordisk Inc | 1 | $113 |
| Boston Scientific Corporation | 3 | $87 |
| La Jolla Pharmaceutical Company | 1 | $17 |
Products named: REPATHA, WATCHMAN FLX, WAINUA, GIAPREZA, EVENITY.
Industry payments across GA — which companies pay providers there.
